UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 28, 2025 9:00 A.M.
Form:
F-1
CIK:
0002038033
Company Name:
GenEmbryomics Ltd
File Number:
333-285074